1 Min Read
Nov 14 (Reuters) - Theratechnologies Inc:
* Theratechnologies Inc says announces decision by FDA to extend ibalizumab review period to April 3, 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.